Vir Biotechnology, Inc.
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection unde…
Biotechnology
US, San Francisco [HQ]
Lobbying · US Senate · Influence
Lobbying Analysis
Lobbying · US Senate · Influence
Vir Biotechnology, Inc. has no lobbying expenses in our database.
| FY | Quarter | Lobby Expense [in mil. $] | Filing | Report Time |
|---|---|---|---|---|
| No data |